Old Web
English
Sign In
Acemap
>
authorDetail
>
S. Safer Demirbuker
S. Safer Demirbuker
Physical therapy
Medicine
Intensive care medicine
Epidemiology
Neurology
4
Papers
9
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Real-world longitudinal data of peginterferon beta-1a from a Swedish national post-marketing surveillance study (IMSE 6) - efficacy and safety profile
2018
Multiple Sclerosis Journal
S. Kågström
A. Fält
S. Safer Demirbuker
A Berglund
Jan Hillert
Peter Nilsson
Charlotte Dahle
Anders Svenningsson
Jan Lycke
A-M Landtblom
Joachim Burman
C. Martin
Peter Sundström
Martin Gunnarsson
F. Piehl
T. Olsson
Show All
Source
Cite
Save
Citations (0)
A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of fingolimod (IMSE 2)
2018
Multiple Sclerosis Journal
S. Safer Demirbuker
S. Kågström
A. Fält
Jan Hillert
Peter Nilsson
Charlotte Dahle
Anders Svenningsson
Jan Lycke
Anne-Marie Landtblom
Joachim Burman
Peter Sundström
C. Martin
Martin Gunnarsson
F. Piehl
Tomas Olsson
Show All
Source
Cite
Save
Citations (4)
A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of alemtuzumab (IMSE 3)
2018
Multiple Sclerosis Journal
A. Fält
S. Kågström
S. Safer Demirbuker
Jan Hillert
Peter Nilsson
Charlotte Dahle
Anders Svenningsson
Jan Lycke
A-M Landtblom
Joachim Burman
C. Martin
Peter Sundström
Martin Gunnarsson
F. Piehl
Tomas Olsson
Show All
Source
Cite
Save
Citations (0)
A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of natalizumab (IMSE 1)
2016
Multiple Sclerosis Journal
A. Fält
S. Kågström
S. Safer Demirbuker
Jan Hillert
Peter Nilsson
Charlotte Dahle
Anders Svenningsson
Jan Lycke
Anne-Marie Landtblom
Joachim Burman
Claes Martin
Peter Sundström
Martin Gunnarsson
F. Piehl
Tomas Olsson
Show All
Source
Cite
Save
Citations (5)
1